Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer

Triple-negative breast cancer (TNBC) displays an aggressive clinical course, heightened metastatic potential, and is linked to poor survival rates. Through its lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), this subt...

Descripción completa

Detalles Bibliográficos
Autores principales: Dees, Sundee, Pontiggia, Laura, Jasmin, Jean-Francois, Mercier, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515519/
https://www.ncbi.nlm.nih.gov/pubmed/32164483
http://dx.doi.org/10.1080/15384047.2020.1726718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515519/
https://www.ncbi.nlm.nih.gov/pubmed/32164483
http://dx.doi.org/10.1080/15384047.2020.1726718

Ejemplares similares